Under Indian surrogacy regulations and medical safety standards, the surrogate's husband must undergo mandatory infectious disease screening prior to cycle clearance. This routine panel primarily screens for sexually transmitted and blood-borne infections, specifically HIV (types 1 and 2), Hepatitis B surface antigen (HBsAg), Hepatitis C virus antibodies (anti-HCV), and Syphilis (VDRL or RPR).
Because marital partners share infection risks, ensuring the husband is free of active transmissible conditions protects the surrogate and the carrying pregnancy from cross-infection. Additional investigations may sometimes be required based on clinical history. Please consult your fertility specialist to obtain the exact, up-to-date panel required for your specific center and legal documentation.
For more, read Understanding Surrogate Meaning And The Process Of Surrogacy; consult Ananya Hospital; reference: WHO guidance on infertility.
A surrogacy journey requires thorough safeguards to protect everyone involved, especially the health of the surrogate mother and the developing baby. In India, clinical protocols mandate that the surrogate's husband completes infectious disease screening before the cycle is approved.
The standard battery includes tests for HIV 1 and 2, Hepatitis B (HBsAg), Hepatitis C (anti-HCV), and Syphilis (VDRL or equivalent). Testing the partner is essential to ensure no latent or active sexually transmitted infections could pass to the surrogate during the medical process or gestation. I encourage you to speak with your treating fertility consultant to review the formal panel and personalized cycle requirements.
For more, read Understanding Surrogate Meaning And The Process Of Surrogacy; consult Dr. Malti Madhu; reference: WHO guidance on infertility.
Cycle clearance in surrogacy involves strict adherence to Indian ART and surrogacy guidelines. Because intimate partners can transmit viral or bacterial illnesses, the surrogate's spouse must be fully evaluated before embryo transfer protocols begin.
The required infectious disease panel includes screening for HIV types 1 and 2, Hepatitis B Surface Antigen (HBsAg), Hepatitis C antibodies (HCV), and Syphilis via VDRL or RPR testing. Verifying negative serology prevents cross-exposure that could otherwise jeopardize maternal safety or embryonic health. Depending on institutional protocols, additional swabs or blood tests might be requested, so we always advise consulting your fertility doctor for your cycle-specific checklist.
For more, read Understanding Surrogate Meaning And The Process Of Surrogacy; consult Nulife Test Tube Baby Centre (Tara Nursing Home); reference: WHO guidance on infertility.
Ensuring a healthy, protected environment for pregnancy is the foundation of fertility care. Under standard Indian regulatory and ethical norms, infectious disease testing extends to the surrogate's husband before any medical cycle begins.
The mandatory panel checks for major transmissible infections: HIV (I & II), Hepatitis B (HBsAg), Hepatitis C (Anti-HCV), and Syphilis (VDRL or TPHA). Routine screening prevents the unintentional introduction of infections that could complicate the pregnancy or compromise the surrogate's well-being. Because individual health backgrounds and clinic accreditations can sometimes necessitate supplementary tests, we recommend consulting your fertility specialist for direct, case-specific guidance.
For more, read Understanding Surrogate Meaning And The Process Of Surrogacy; consult Srushti Women's Clinic & Fertility Centre - Kotturpuram; reference: WHO guidance on infertility.
Before proceeding with cycle approval, Indian surrogacy protocols mandate infectious disease clearance for both the surrogate and her husband. The husband's panel is crucial to prevent the transmission of sexually transmitted pathogens during the treatment timeline.
The primary tests include serology for HIV 1 and 2, Hepatitis B (HBsAg), Hepatitis C (HCV), and Syphilis (VDRL or RPR). These evaluations protect the surrogate's reproductive health, thereby supporting a secure environment for the carried fetus. Depending on the clinical scenario or regional medical board directives, further tests may occasionally be warranted. Please consult your reproductive gynecologist for detailed advice tailored to your medical and legal plan.
For more, read Understanding Surrogate Meaning And The Process Of Surrogacy; consult Dr. Payal Mahapatra; reference: WHO guidance on infertility.
Your insights help others make informed choices. Don’t hesitate to share!
Which option do you think is more emotionally fulfilling?
19 September 2026